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Abstracts for plenary sessions
P1
Using Patient Reported Outcome Measures (PROMs) in cancer care
Galina Velikova
Leeds Institute of Cancer & Pathology, University of Leeds and Leeds
Teaching Hospitals, Leeds, UK
Health and Quality of Life Outcomes 2017, 15(Suppl 1):P1
Monitoring of patients’ physical and psychological problems during
and after cancer treatment is essential in modern oncology practice.
Traditional clinical methods can be supplemented by Patient-
Reported Outcomes Measures (PROMs) measures. The potential role
of PROMs is recognised and endorsed by national and international
practice guidelines. The introduction of formal measurement of
PROMs in clinical practice is a complex health care innovation requir-
ing careful planning, design and successful implementation of a
number of essential components, such as choosing the patient ques-
tionnaire(s), a convenient affordable electronic method for reporting
and display in hospital records and engaging clinicians to use and
act on the reports. There is mounting research evidence that using
PROMs in individual patient care in oncology is beneficial to patients,
but this approach has not found a place in routine clinical practice. A
brief overview of this evidence will be provided. Following this, the
presentation will focus on examples of incorporating PROMs and
eHealth interventions into routine patient care during and after can-
cer treatment, drawing on 20 years’ experience in Leeds of using
electronic systems for capturing patient reported data in oncology
settings. Examples will be given of: 1) Monitoring toxicity during
systemic cancer treatment using online PROMs integrated with
Electronic Patient Records (randomized trial part of NIHR eRAPID
programme); 2) Service development project - Remote follow-up of
testicular cancer patients using online PROMs plus community-based
investigations. Examples of other online PROMs systems will be
presented. The values and challenges of PROMs integration in
routine oncology practice will be discussed.
P2
The National Institutes of Health Patient-Reported Outcomes
Measurement Information System (PROMIS): a view from the UK
Jose M Valderas1,2
1Health Services & Policy Research Group, University of Exeter Medical
School, Exeter UK; 2Exeter Collaboration for Academic Primary Care
(APEx), Exeter, UK
Health and Quality of Life Outcomes 2017, 15(Suppl 1):P2
The Patient-Reported Outcomes Measurement Information System
(PROMIS) is a system for the measurement of patient reported out-
comes whose development was funded by the US National Institute
for Health. Its methodological rigor, scope, ambition and flexibility
(including both standardized short forms and computerized adaptive
administration) has turned it into one of the standards of PROMs
measurement, although its use is still very limited outside the US.
The presentation will provide an overview of the rationale for the de-
velopment of the system, the methods employed in its development
and the resulting scales and short forms and key characteristics, in-
cluding Assessment Centre, the online platform supporting the use
of PROMIs scales. Current applications and use of PROMIS in the UK
will be reviewed and the potential for its application to support the
management of patients in the NHS will be considered.
Abstracts for oral papers
Session 1a. Development and validation of
measures - 1
A66
Validation of the Long-Term Conditions Questionnaire (LTCQ) in a
diverse sample of health and social care users in England
Caroline Potter1,4, Laurie Batchelder2,3, Christine A’Court1, Matthew Baker3,
Jennifer Bostock3, Angela Coulter1,3, Ray Fitzpatrick1,3,4, Julien Forder2,3,
Diane Fox2,3, Louise Geneen1,3, Elizabeth Gibbons1,4, Crispin Jenkinson1,3,
Karen Jones2,3, Laura Kelly1,4 & Michele Peters1,3
1University of Oxford, Oxford, UK; 2University of Kent, Canterbury, UK;
3QORU: Quality and Outcomes of Person-centered Care Policy Research
Unit, Department of Health England, Canterbury, Kent, UK; 4NIHR
Collaboration for Leadership in Applied Health Research and Care
(CLAHRC) Oxford, Oxford, UK
Correspondence: Caroline Potter
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A66
Background: Long-term conditions (LTCs) have emerged as a signifi-
cant challenge to the sustainability of health systems. The rise of
multi-morbidity has highlighted the need for joined-up services that
can enhance people’s capacity for living well with LTCs.
Aims: The objective of this study was to validate a new generic well-
being measure, the Long-Term Conditions Questionnaire (LTCQ).
Methods: Data were collected through two postal surveys (main and
follow-up) from February 2016 to January 2017. The study sample in-
cluded 1) a health care cohort of patients with at least one of 11 spe-
cified LTCs recruited through primary care practices and 2) a social
care cohort receiving support for at least one LTC recruited through
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Local Authorities. The LTCQ’s construct validity was tested with refer-
ence to the EQ-5D (5-level version), Self-efficacy for Managing
Chronic Disease scale, an Activities of Daily Living scale, and the
Bayliss multi-morbidity scale. The follow-up survey enabled assess-
ment of test-retest reliability.
Results: The total sample (N = 1,211; 23% response rate; 24% con-
firmed social care users) exhibited high multi-morbidity, with 93%
reporting two or more LTCs and 43% reporting a mental health con-
dition. Low levels of missing data indicate acceptability of the LTCQ
within this diverse sample. The LTCQ exhibits high internal
consistency (Cronbach’s α = 0.95) across the scale’s 20 items and ex-
cellent test-retest reliability (ICC = 0.94, 95% CI 0.93 to 0.95). Associa-
tions between the LTCQ and all reference measures were moderate
to strong and in the expected directions, indicating convergent con-
struct validity.
Conclusions: This study provides evidence for the reliability and val-
idity of the Long-Term Conditions Questionnaire, which has potential
for use in a variety of health and social care settings. The LTCQ could
meet a need for an outcome measure that goes beyond symptoms
and physical function, providing a more holistic metric for living well
with LTCs.
A15
Developing preference based measures for diabetes for calculating
QALYs: DHP-3D and DHP-5D
Brendan Mulhern3, Alexander Labeit1, Donna Rowen1, Keith Meadows2,
Jackie Elliott1, John Brazier1 & Emma Knowles1
1University of Sheffield, Sheffield, UK; 2Oxford University Innovation,
Oxford, UK; 3University of Technology, Sydney, Sydney, Australia
Correspondence: John Brazier
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A15
Background: The cost per quality adjusted life year (QALY) of new in-
terventions in long term conditions (LTCs) is assessed to inform re-
source allocation decisions. However, generic preference-based
measures of health like EQ-5D may not be sufficiently sensitive for
some LTCs. Condition specific PROMS like the Diabetes Health Profile
(DHP) offer more relevant descriptions of how LTCs impact on peo-
ple’s lives.
Aims: The aim was to develop two diabetes specific preference
based measures (DHP-3D/DHP-5D) for use in the calculation of
QALYs based on the non-preference based DHP (DHP-18/DHP-1).
Methods: For DHP-3D, Exploratory Factor Analysis and Rasch ana-
lyses were used to understand the dimensionality of the DHP-18,
and select items to represent each in the classification system. The
DHP-5D built on the DHP-3D adding two dimensions to extend the
range of diabetes related impacts assessed. Each was valued by 150
members of the UK general public using the Time Trade Off (TTO)
preference elicitation method. The valuation data was modelled
using individual and mean level multivariate regression to produce
utility values for every health state described.
Results: The DHP-3D classification system included three dimensions
in line with the structure of the DHP-18 defined as mood, eating and
social limitations, and the DHP-5D also included dimensions for
hypoglycemic attacks and vitality. For both, the random effects gen-
eralized least squares regression model produced the most valid util-
ity value set, with the DHP-3D and DHP-5D ranging from 0.983 (best
state) to 0.717(worst state), and 0.979 to 0.618 respectively. The
addition of the two extra dimensions leads to significant differences
for the more severe levels of each matched dimension.
Conclusions: We have developed two diabetes specific preference
based measures that, subject to psychometric assessment, can be
used to provide condition specific utility values to complement gen-
eric utilities from more widely validated measures such as the EQ-5D.
A62
Constructing and Validating the Short Recovering Quality of Life
(ReQoL) Measure for Use in a Mental Health Population
Anju Keetharuth, John Brazier, Janice Connell, Jill Carlton,
Lizzie Taylor Buck, Thomas Ricketts & Michael Barkham
University of Sheffield, Sheffield, UK
Correspondence: Anju Keetharuth
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A62
Background: The concept of recovery for people experiencing men-
tal health difficulties has received greater emphasis recently, prompt-
ing demands for new measures.
Aims: To assess the outcomes of mental health services in terms of
recovering quality of life, we constructed and validated a 10-item
version ReQoL measure.
Methods: After having established seven themes, we generated a
long list of potential items which were tested for content validity.
Psychometric analyses used confirmatory factor models and item
response theory (IRT) analyses with particular focus on item fit and
item information functions. A novel approach was developed to
present qualitative and quantitative evidence to a group of service
users, clinicians and researchers to make the final selection. Internal
consistency was assessed using Cronbach’s alpha. Known group dif-
ferences were calculated to test whether the scale was able to dis-
criminate between groups with pre-specified hypotheses. Sensitivity
to change was measured between baseline and follow-up for a
group of people attending services. The ReQoL was compared with
EQ-5D and SWEMWBS.
Results: Qualitative evidence from over 90 service users was used to
reduce the number of items before field-trial quantitative data were
collected from over 6200 service users. Factor analyses supported a
unidimensional model. Evaluation of IRT test information functions
suggested that a 10 item scale could cover as wide a measurement
range as the pool of 40 items. A Cronbach alpha of 0.92 showed
good internal reliability. The scale showed moderate responsiveness
to change with a standardised response mean of 0.4 for those whose
health improved and worsened. The ReQoL was able to detect
known group differences and compared well with other measures.
Conclusion: This work provides a pragmatic yet rigorous approach to
combining qualitative and quantitative evidence to develop the
ReQoL to be both psychometrically robust and likely to have high
face validity with service users and clinicians.
Session 1b. Qualitative evidence
A59
Development of a novel patient reported outcome measure for
patients with haematological malignancy: a qualitative study
Pushpendra Goswami1, Sam Salek1, Tatyana Ionova2, Esther Oliva3,
Adele K Fielding4, Marina Karakantza5, Saad Al-Ismail6, Graham P Collins7,
Stewart McConnell5, Catherine Langton5, Daniel M Jennings8,
Roger Else9, Jonathan Kell10
1School of Life and Medical Sciences, University of Hertfordshire,
Hatfield, Hertfordshire, UK; 2National Medical Surgical Centre and
Multinational Centre for Quality of Life Research, St Petersburg, Russia;
3Haematology Unit, Azienda Ospedaliera, Reggio Calabria, Italy; 4UCL
Cancer Institute, London, UK; 5Leeds Teaching Hospitals NHS Trust,
Leeds, UK; 6Singleton Hospital, ABM University Health Board, Swansea,
UK; 7Oxford University Hospitals NHS Trust, Oxford, UK; 8Royal Surrey
County Hospital NHS Foundation Trust, Guildford, Surrey, UK; 9Patient
Research Partner, Milton Keynes, UK; 10Cardiff and Vale University Health
Board, Cardiff, UK
Correspondence: Pushpendra Goswami
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Aims: The impact of haematological malignancies (HM) and its treat-
ment on patients’ health-related quality of life (HRQoL) is still not
well understood. The aim of this study was to identify HRQoL issues
and symptoms in patients with HM.
Methods: In a UK based multicentre cross-sectional prospective
study, adult patients with various HM were recruited from six hospi-
tals in England and Wales. The study employed semi-structured face-
to-face interviews with open-ended questions related to the impact
of HM and its treatment on HRQoL and symptoms. All the interviews
were audio recorded, transcribed verbatim and content analysed
using NVivo 11, a qualitative data analysis software.
Results: 129 patients (male = 76; mean age = 61.1 years; SD = 15.3;
median age =64.92 years; and age range =18-88 years) with mean
duration of the HM of 3.6 years (SD = 4.3; and range = 19 days-
23 years) were interviewed. Diagnoses were: Acute Myeloid Leukae-
mia (18); Acute Lymphoid Leukaemia (7); Chronic Myeloid Leukaemia
(12); Chronic Lymphocitic Leukaemia (11); Aggressive Non-Hodgkin’s
Lymphoma (17); Indolent Non-Hodgkin’s Lymphoma (14); Hodgkin’s
Lymphoma (11); Multiple Myeloma (21); Myeloproliferative Neo-
plasms (10); and Myelodysplastic Syndromes (8). The most prevalent
QoL issues important to HM patients were: eating and drinking
habits (117); impaired social life and participatory function (86); im-
paired physical ability or independency (70); disturbed sleep (66);
and impaired psychological well-being (64). The most prevalent
disease symptoms were tiredness (66); feeling unwell (28); breathless-
ness (24); lack of energy (21); and back pain (18). Most prevalent
treatment side effects were: tiredness (74); feeling sick (36); lack of
energy (20); taste disturbance (20); and breathlessness (16)’.
Conclusion: The findings clearly indicate that HMs significantly
affect patients’ QoL, which is not captured in a systematic man-
ner in routine clinical practice. This highlights the need for the
development and validation of a new HM-specific PRO measure
for use in such settings.
A43
“Normal is redefined”; reflections on outcomes for women with
breast cancer: an ethnographic study in London
Helen Ward1 & Sophie Day1,2
1Imperial College London, London, UK; 2Goldsmiths College, London, UK
Correspondence: Helen Ward
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A43
Background: Prognosis for breast cancer is improving with 78% of
women surviving >10 years. We conducted an ethnographic study of
breast cancer care which focused on experience rather than out-
comes, but revealed relevant themes.
Aim: To identify outcomes valued by women with breast cancer.
Methods: Secondary analysis of ethnographic data including 79
interviews (patients, staff, carers).
Results: Women referred to different concerns, preferences and aspi-
rations. Desired outcomes were affected by the experience of treat-
ment, changed over time, and influenced decisions about care. Three
major themes emerged.
 Dependency: the dominant theme was a determination not to
become dependent, and to continue to care for others.
Women described children, partners and parents who they
‘took care of’. This priority affected how they hoped to balance
quality and quantity of life; some chose less aggressive
treatments in order to have a “decent quality of life to carry
on”, others chose radical treatments to maximise their chance
of ‘staying around’.
 Normality: some women looked forward to ‘getting back to
normal’ but others recognised that they would never be the
same again. One described how difficult it would be to resume
her previous life, “you are changed, recalibrated, normal is
redefined”. Specific aspirations included looking forward to
your hair growing back, returning to work, attending a
wedding, kayaking, a grandchild starting university. Some
women worried about work, asking how they would cope
financially, and how they could avoid pity.
 Reciprocity: In addition to some who planned new careers
supporting people with cancer, several women aspired to ‘give
back’ through volunteering, fund-raising and taking part in
research.
Conclusions: These themes illustrate the complexity of defining
standard patient reported outcomes. We should recognise and re-
spond to evolving preferences and priorities of individuals, avoiding
a narrow focus on outcomes defined by other patients.
A16
Examining the relevance of PROMs to patients: A review of
qualitative data capturing which HRQoL domains are important to
patients
Elizabeth Lumley1,2, Patrick Phillips2, 1, Rosie Duncan1, Helen Buckley-Woods1,
Ahmed Aber1, Gerogina Jones3 & Jonathan Michaels1
1The University of Sheffield, Sheffield, UK; 2Sheffield Teaching Hospitals
NHS Foundation Trust, Sheffield, UK; 3Leeds Beckett University, Leeds, UK
Correspondence: Elizabeth Lumley
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A16
Background: Patient reported outcome measures (PROMs) allow
measurement of outcomes elicited from patients; therefore PROMs
should include domains that are relevant to patients. One source of
this information may be existing qualitative research describing pa-
tient experiences and their impact on quality of life (QoL).
Aims: The aim of this qualitative evidence synthesis was to examine
the symptoms and QoL domains that are important from the per-
spective of a patient with varicose veins (VV), and compare them to
existing PROMs domains.
Methods: Eight electronic databases were searched to identify quali-
tative research published in English of the experiences of adults with
VV. A thematic analysis was conducted and resulting themes were
compared to existing VV PROM domains to evaluate if they captured
the impact the VV have on patients.
Results: A total of 1804 citations were identified; after screening only
three studies met the inclusion criteria. Five overarching themes
were described in the studies; physical impact, psychological impact,
social impact, adapting to VV and reasons for seeking treatment.
Discussion: The range and intensity of reported symptoms and the
participant’s experience of VV was very varied. One key theme to
emerge was adaptation, as there was evidence that patients
attempted to adapt to the physical, psychological and social impact
of VV. No PROM currently exists that would capture how VV patients
adapt their lives.
Conclusion: The use of PROMS to gather information is well estab-
lished in the NHS but those currently used may not capture the full im-
pact. Qualitative research methods allow an in-depth understanding of
the range and severity of symptoms experienced by patients, and the
impact these may have. Dimensions of PROMs should be based on pa-
tient experiences, best generated by qualitative research methods.
A71
Perspectives of patients and professionals on the use of patient-
reported outcome measures in primary care: a systematic review
of qualitative studies
Ian Porter1, Jaheeda Gangannagaripalli1, Antoinette Davey1,
Ignacio Ricci-Cabello2, Kirstie Haywood3, Stine Thestrup Hansen4,5
& Jose Valderas1
1University of Exeter Medical School, Devon, UK; 2Nuffield Department of
Primary Care Health Sciences, University of Oxford, Oxfordshire, UK;
3Royal College of Nursing Research Institute, University of Warwick,
Warwickshire, UK; 4Department of Haematology, Zealand University
Hospital, Køge, Denmark; 5Department of Regional Health Research,
University of Southern Denmark, Odense, Denmark
Correspondence: Ian Porter
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A71
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Background: Although the use of patient-reported outcome measures
(PROMs) in healthcare settings has increased substantially over recent
years, there is potential for them to play a greater role in primary care.
Aim: The underlying aim was to review and summarise studies ex-
ploring patients’ and health professionals’ perspectives on the use of
PROMs in primary care, to identify positive and negative factors asso-
ciated with their use, along with barriers and enablers.
Methods: A qualitative systematic review was conducted in Medline,
Embase, PsychInfo and CINAHL from inception until 2016; further
relevant references were retrieved through snowballing. Eligible stud-
ies were conducted in primary care settings, using qualitative
methods, exploring patients and/or healthcare professional’s perspec-
tives on the clinical utility of using PROMs in clinical practice.
Results: 19 studies met the inclusion criteria (4 after 2012), 11 of
which were conducted in the UK, reporting on the views of profes-
sionals (8), patients (5), and both (7). The majority of studies (12) fo-
cused on mood disorders. Patients identified benefits associated with
PROMs such as increased awareness, alertness, self-management,
feeling validated, and being able to discuss problems they would not
otherwise mention. Concerns were raised about PROMs replacing
face-to-face consultations, restricting discussion, along with worries
about stigma and being identified by illness(es). Professionals re-
ported PROMs to be useful for aiding clinical decisions, monitoring
and management options, aiding a better understanding of the lon-
gitudinal life of patients. Although PROMs were valued for facilitating
communication it was also noted that they undermined the human
element of consultations, along with professional intuition and
judgement. Burden on GP time was also noted.
Conclusions: Patients and professionals highlighted a number of
benefits of using PROMs in clinical practice, particularly in terms of
supporting decision making, patient awareness and management/
self-management options. However, concerns were voiced about
PROMs potentially undermining relational continuity of care.
Session 1c. PROMs for specific patient groups
A53
Subjective Quality of Life (QOL) accounts. Essential for applied
health research into long term conditions (LTC’s)
Deb Roberts
Royal Liverpool & Broadgreen University Hospitals Trust, Merseyside, UK
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A53
Background: This study focuses on QOL measurement in Chronic
Fatigue Syndrome (CFS/ME). A heterogeneous and complex illness
with fluctuating and unpredictable symptoms.
Aims: To pilot a nationally recognised QOL Patient Reported Out-
come Measure (PROM) to improve recording and analysis of patients’
personal accounts. To produce accessible data for clinical and re-
search settings, with direct relevance to patient care and commis-
sioning decisions.
Design and Methods: A scoping exercise appraised current practices
and reviewed relevant measures. By CFS/ME specialist consensus, the
World Health Organisation’s QOL PROM of 26 items (WHOQOLBREF-26)
was completed with ten patient volunteers. Following a positive profes-
sional evaluation, the initiative was registered as a host trust Improve-
ment, Quality and Efficiency project (QEP). A sample of one hundred
patients completed the questionnaire in addition to the recommended
PROM’s 1. before treatment and 2. after attending group sessions, at
the start of individual therapy contact. Quantitative analysis compared
longitudinally and to existing tools results.
Results: Standard practice, advocated by the British CFS/ME Association
of Professionals (BACME) does not fully reflect patients’ self-reporting of
CFS/ME. The literature emphasised QOL PROM’s but failed to reveal a
universally agreed CFS specific measure. The popular Short Form 36
items (SF36) was regarded as more of a health status tool. Therapists
observed ease of administration and interpretation. Change suffi-
cient to endorse the NICE Guidelines for CFS/ME rehabilitation,
enhance therapeutic encounters and commissioning decisions
was demonstrated. The project outcomes are comparable to
other research in this field.
Conclusion: Well validated PROM’s are applied in CFS practice and
research but exhibit wide variation and lack sensitivity. Although the
sample is modest, the WHOQOLBREF-26 provides a quantifiable per-
spective of the impact of CFS/ME for applied research and clinical ap-
plication. It shows transferability to the research and evaluation of
care in other LTC’s.
A33
Effects of Out-of-Pocket (OOP) Payments and Financial Distress on
Quality of Life (QoL) of People with Parkinson’s (PwP) and their
Carers
Anil Gumber
Centre for Health and Social Care Research, Sheffield Hallam University,
Sheffield, UK
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A33
Background: Parkinson’s, a neurodegenerative disorder largely affect-
ing the older population, develops into gradual loss of both motor
and non-motor functions, thus impacting their daily living activities.
In the UK, over 127,000 people and families are affected by Parkin-
son’s. Evidence shows an increased financial burden on families who
are managing and caring for PwP.
Aims: To explore effects of OOP expenditure and loss of income on
quality of life and wellbeing of PwP and their caregivers in the UK.
Methods: The on-line survey collected information from 853 PwP
and caregivers across the UK on changes in their economic, social,
health and living conditions due to Parkinson’s during 2015–16.
Multivariate regression analyses were attempted, after adjusting for
socio-demographic variables, to estimate the net effect of OOP ex-
penditure and income loss on QALYs, VAS and wellbeing scores (on
life-satisfaction, life worthwhile, happiness and anxiousness) of PwP
and their main carers.
Results: QALY, VAS and wellbeing scores of PwP were negatively as-
sociated with since how long they were diagnosed with Parkinson’s,
i.e. disease progression. Mean OOP cost of treatment and care also
increased with the duration of Parkinson’s. Significant negative rela-
tionships were found between OOP expenses and income loss on
QoL of PwP as well as that of their carers. Magnitudes of coefficients
were much higher in PwPs having the condition for >15 years. Simi-
lar effects but of smaller magnitudes were found on QoL and well-
being of carers by duration of disease/ how long caring for. QoL was
significantly lower in families having annual income < £20,000.
Conclusions: The management and care of Parkinson’s has resulted
in considerable financial burden on PwP and their families, which fur-
ther contributed in deterioration in their quality of life and wellbeing.
There is a need to include financial distress indicators in PROMs for
those having degenerative conditions including cancers.
A34
The Impact of Comorbidities on Outcomes of Hip and Knee
Replacement: a meta-analysis
Bélène Podmore1,2, Andrew Hutchings1,2, Jan van der Meulen1,2,
Ajay Aggarwal1 & Sujith Konan3
1London School of Hygiene & Tropical Medicine, London, UK; 2The Royal
College of Surgeons of England, London, UK; 3University College
London Hospitals NHS Foundation Trust, London, UK
Correspondence: Bélène Podmore
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A34
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Background: Joint replacement surgery is one of the most effective
interventions leading to considerable improvements in function and
quality of life. Increasing numbers of patients with long-term condi-
tions are undergoing joint replacement surgery. It is important to
understand how comorbid conditions impact on outcomes of joint
replacement.
Aim: This meta-analysis investigated the impact of comorbidities on
outcomes of hip and knee replacements.
Methods: This study sought all studies that assessed the impact of
comorbidities on outcomes of hip and knee replacements. We ex-
tracted data for the eleven comorbidities that are recorded in the
NHS National PROMs programme. We estimated pooled odds ratios
(OR) that express the impact of these comorbidities on ten outcomes
including function, pain and health-related quality of life. Differences
in continuous outcomes were converted to OR following the Hassel-
blad and Hedges approach.
Results: Fifty-six papers were included. Of these, ten papers looked
at function, ten at pain and five at quality of life. Measures that were
used for function and pain included the Oxford Knee Score, Knee So-
ciety Score, ADL limitation and the WOMAC. For quality of life, the
SF-12, SF-36 and Health Utilities Index were used. The evidence sug-
gests comorbidities lead to significantly worse outcomes in the
short-term (surgical complications, readmissions, short-term mortal-
ity). The evidence for an impact of comorbidities on long-term out-
comes is weak however, and the pooled results vary across the
different outcomes: quality of life (OR ranging from 0.36 to 1.49),
function (OR ranging from 0.68 to 1.69), and pain (OR ranging from
1.01 to 1.41).
Conclusions: This meta-analysis shows that comorbidities have an
impact in the short-term on outcomes relating to the safety of the
surgery but that there is little or no evidence that patients with co-
morbidities benefit less from hip and knee replacement surgery in
the long-term than patients without.
A79
Extending the use of PROM scores in the Hip and Knee
Replacemnt Patient Pathway in the NHS - Enhancing response
rates through patient engagement
Andrew Price, William Jackson, Nick Bottomley, Michael Philiips,
Toby Knightley-Day, David Beard
University of Oxford, Oxford, UK
Correspondence: William Jackson
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A79
Background: The National Oxford Hip anf Knee PROMs collection for
joint replacement is detached from the patients routine NHS care
pathway and has a response rate of 60%.
Aims: The aim of this study is to examine whether embedding the
use of electroinc PROM score collection in the care pathway, creating
value for patients, improves repsonse rates.
Methods: The Oxford hip and Knee scores were embedded into the
clinical pathway. Using a cloud based eplatform scores were used to
supoort decision making prior to surgery, to record the base line level
of pre-operative symptoms, to monitor early outcome and to offer
longer-term surveillance of outcome. PROMs data was shared with pa-
tients at all stages, with the format guided by PPI development input.
The response rate at 1-year follow-up was recorded. Comparison was
made to standard NHS PROMs collection as a control.
Results: Patients stated that electronic PROMs collection was a useful
addtion to the pathway. Patients used the following channels to rec-
ord post-operative ePROM scores: tablet, smart-phone, lap-tops and
desk-top PC. The response rate for 1-year follow-up Oxford Score
was 90% using all electronic collection methods. During the same
time period standard NHS PROM collection repsonse rate was 59% in
the control arm.
Conclusions: PROM scores can be used to enhance the patients
pathway for Hip and Knee Replacement surgery in the NHS. Patients
enagagement in PROM use resulted in a significant increase in re-
sponse rate at longer term follow-up.
Session 2a. PROMs into practice
A06
The Musculoskeletal Health Questionnaire (MSK-HQ): a partnership
model of implementation to assess acceptability, feasibility and
impact
Elizabeth Gibbons & Ray Fitzpatrick
Nuffield Department of Population Health, University of Oxford,
Oxford, UK
Correspondence: Elizabeth Gibbons
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A06
Background: The Musculoskeletal Health Questionnaire (MSK-HQ) is
a short self-completed questionnaire intended to be broadly applic-
able to assess the impact of musculoskeletal problems on patient’s
daily life. 1 This provides a case study of how to promote adoption
of a PROM in the health service.
Aim: The aim was to gain insights into how the MKS-HQ is used by
early adopters as a resource to support organisational decision mak-
ing about services and impact on individual patient care.
Methods: A partnership approach to implementation was adopted; a
collaboration between a charity (ARUK), researchers and n = 10 part-
ners providing a range of MSK services. Interim interviews were
conducted over a one year period to share emerging experiences,
successes and challenges. Interviews were audio recorded and tran-
scribed and framework analysis conducted using NVivo 10.
Results: Logistics and feasibility: Several partners experienced delays in
implementation due to reconfiguration of services and installation of
new clinical systems. Some experienced challenges with negotiating
external processing for electronic capture and data governance.
Capacity to process and analyse data was variable; some sites utilised
external contractors whilst others relied on existing analytical support.
Interpretability: The minimally important difference (MID) was consid-
ered fundamental to interpretation and partners explored different
methods of presentation of data. Individual item responses were
considered valuable and actionable, specifically items related to in-
formation needs and self-management.
Acceptability: The MSK-HQ was acceptable to patients; easy to
complete and relevant to their condition. A high level of staff en-
gagement and confidence in the measure was evident with some
staff reporting a more structured appointment resulting in more time
for the delivery of treatment.
Conclusion: Despite some challenges, the MSK-HQ appears to be ac-
ceptable, feasible and useful for clinical decision making Partnership
between charities, academics and local NHS services are a promising
mechanism to implement PROMs.
A56
When, how and why does PROMs feedback improve clinician-patient
communication within the consultation? A realist synthesis
Joanne Greenhalgh1, Kate Gooding2, Elizabeth Gibbons3,
Chema Valderas4, Judy Wright1, Sonia Dalkin6, David Meads1
& Nick Black5
1University of Leeds, Leeds, UK; 2University of Liverpool, Liverpool, UK;
3University of Oxford, Oxford, UK; 4University of Exeter, Exeter, UK;
5London School of Hygiene and Tropical Medicine, London, UK;
6Northumbria University, Newcastle-upon-Tyne, UK
Correspondence: Joanne Greenhalgh
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A56
Background: It is suggested that the use of patient reported out-
come measure (PROMs) in clinical practice can enhance patients’
consultations with clinicians and improve clinical management.
Methods: A realist synthesis to explore the contexts in which and
processes through which PROMs enable patients to share concerns
with clinicians and change clinicians’ communication practices. We
identified the ideas and assumptions (theories) underlying how
PROMs use was intended to work. Electronic databases were
searched and backwards and forward citation tracking were carried
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out on key systematic reviews. We selected papers relevant to testing
our theories and 36 papers were included.
Results: PROMs completion prompts patients to engage in self-
reflection about their health. Whether PROMs supported or con-
strained patients in sharing issues with clinicians depended on the
structure of the PROM and existing clinician-patient relationship.
Clinicians perceived standardised PROMs constrained their relation-
ship with patients and were difficult to incorporate into the flow of
consultations. Clinicians avoided using them or adapted the PROM,
which may compromise their validity. Individualised PROMs sup-
ported consultations by allowing patients to ‘tell their story’ but were
less useful as an outcome measure. In oncology, PROMs did not sub-
stantially change clinicians’ communication practices; consultations
focused largely on symptoms rather than psychosocial issues.
Conclusions: It is the process of PROMs completion which helps
patients to reflect on their health and raise issues with clinicians. The
structure of the PROMs was a key determinant of the extent to which
the use of PROMs supported or constrained the clinician-patient rela-
tionship. Future research should consider how PROMs support the
relationship building function of the consultation, rather than just
the information exchange and decision making functions.
A51
Converging and diverging views about PROMs: a qualitative study
involving patients and clinicians
Carol Fawkes1, Robert Froud2,3 & Dawn Carnes1
1Barts and the London School of Medicine and Dentistry, London, UK;
2Warwick Medical School Clinical Trials Unit, Coventry, UK; 3Norges
Helsehøyskole, Campus Kristiania, Oslo, Norway
Correspondence: Carol Fawkes
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Background: Although the use of Patient Reported Outcome Mea-
sures (PROMs) is being advocated increasingly in clinical practice,
there has been a lack of input from patients and clinicians into this
process. The success of new initiatives rests on engagement from
both of these groups.
Aims: To explore the views of patients and clinicians concerning the
use of PROMs in musculoskeletal healthcare practice.
Method: A combination of focus groups and individual interviews
were undertaken with patients and clinicians. A topic guide was used
to support semi-structured interviews and focus groups which were
audio-recorded. All transcripts were transcribed verbatim and analysed
using the Framework approach. Themes and sub-themes were identi-
fied, and explanatory models were developed to describe the data.
Results: Interviews were held with patients (N = 18) and clinicians
(N = 46) from around the United Kingdom. Clinicians and patients
recognised how PROMs could facilitate communication between pa-
tients and healthcare professionals, and among healthcare profes-
sionals, demonstrate the effects of practice, provide the opportunity to
contribute feedback about care, and the importance of having a clear
statement on data use and security. Patients stressed their willingness
to complete PROMs in an electronic format, and the importance of
short questionnaires with a quick completion time. They emphasised
their reluctance for PROMs to disrupt the consultation process, and will-
ingness to seek IT help if required. In contrast, clinicians expressed con-
cerns about patient burden and patients’ IT capability, language
accessibility, and suitability of PROMs for different settings. While reflec-
tion on practice was regarded as important by clinicians, dealing with
patients’ feedback was regarded as challenging.
Conclusions: The clinicians’ concerns about patient burden and IT
capability were not reflected by the patients who were willing to use
PROMs. Patients welcomed the opportunity to provide feedback
about their care.
A78
ACHE - The Arthroplasty Candidacy Help Engine - Using PROMs
data to identify thresholds for referral in hip and knee repalcment
surgery
Andrew Price, Jonathan Cook, Helen Dakin, James Smith, Sujin Kang,
David Beard & The ACHE Study Team
Univeristy of Oxford, Oxford, UK
Correspondence: Helen Dakin
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A78
Background: At present there is no evidence to support the use of
the Oxford PROM scores to set pre-operative thresholds for referral
for hip and knee replacement surgery. Despite this the practice has
been widespread in the NHS.
Objectives/Research Questions: Can the Oxford Hip/Knee scores
(OKS/OHS) be used to set referral thresholds for hip/knee replace-
ment surgery? Does the choice of threshold affect the cost effective-
ness of the procedure?
Methods: Thresholds for the Oxford scores were calculated, based on a
capacity to benefit model linking pre-operative OKS/OHS to the prob-
ability of a good outcome – creating an online ACHE tool. Markov
models were constructed to assess how the cost-effectiveness of TKA
and THA compared with no arthroplasty varies with pre-operative OKS/
OHS over a 10-year time horizon from a UK NHS perspective.
Results: The absolute threshold for the OHS was 41 and 42 for the
OKS. A model was created that used preoperative Oxford scores to esti-
mate the probability of a good outcome allowed – e.g. an OHS of 35 or
an OKS of 30 offers a patient a 70% probability of achieving a good
outcome. The economic evaluation demonstrated that TKA and THA
cost < £20,000 per quality adjusted life-year (QALY) gained for >99.9%
of patients who currently undergo surgery. It is cost-effective to con-
duct TKA on patients with OKS of 43 (95% credible interval, CrI: 43,44)
or less and on patients with THA of 45 or less (95% CrI: 44, 45).
Conclusion: Using the ACHE tool the Oxford Hip/Knee Scores can be
used to assess an individual patients suitability for hip or knee re-
placement surgery. On a population level both interventions are
highly cost-effective right up to the absolute threshold for interven-
tion. The ACHE tool appears to be a useful evidence based clinical
tool to aid referral from primary to secondary care.
Session 2b. Development and validation of
measures – 2
A75
Collaborating with burn patients and their families to develop the
CARe Burn Scales: a portfolio of burn-specific quality of life PROMs
for use in paediatric and adult burn care
Catrin Griffiths, Ella Guest & Diana Harcourt
University of the West of England, Bristol, UK
Correspondence: Catrin Griffiths
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A75
Background: 250,000 people in the UK each year suffer a burn injury.
Those affected can experience life-long difficulties including pain,
trauma, anxiety, depression and body image distress. Currently there
is no standard practice for collecting PROM data in the NHS Burns
Service. Few burn-specific PROMs exist and even less have been de-
veloped with burn patients themselves. In collaboration with adoles-
cents and adults with a burn injury, family members and health
professionals (HPs), we developed the CARe Burn scales: a portfolio
of quality of life burn-specific PROMs for use in child, young people,
and adult burn care.
Aim: To incorporate the opinions of patients and family members in
the development of the CARe Burn Scales.
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Method: Semi-structured interviews were carried out with patients
(n = 19), family members (n = 25) and health professionals (n = 8).
Thematic analysis identified a number of issues experienced by indi-
viduals who are living, or supporting someone, with a burn-injury.
The findings informed item generation and the conceptual frame-
work for each PROM. Two systematic reviews of the PROMs currently
used in paediatric and adult burn care were also conducted to in-
form the PROM development. Three age-specific PROMs for children
(aged under 8), young people (aged 8–17) and adults (aged 18 and
over) were developed. Twenty cognitive-debriefing interviews were
then conducted with patients, family members and HPs who
reviewed the PROMs in order to identify relevance and readability.
Results: The need for burn-specific PROMs to identify patient needs
in burn care was reinforced, revisions to improve the PROMs were
made and HPs suggested how they would utilise the PROMs within
their practice. Psychometric analysis of the PROMs were then
conducted using Rasch and classical test theory to further refine and
validate the PROMs.
Conclusion: The CARe Burn Scales are now available for use in
research and clinical practice.
A05
Testing the face validity and acceptability of the Primary Care
Outcomes Questionnaires through cognitive interviews
Mairead Murphy, Sandra Hollinghurst & Chris Salisbury
University of Bristol, Bristol, UK
Correspondence: Mairead Murphy
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A05
Background: The Primary Care Outcomes Questionnaire (PCOQ) is a
new patient-reported outcome measure designed specifically for pri-
mary care. It has two formats: the PCOQ-status (which has an adjectival
scale) and the PCOQ-change (which has the same items as the PCOQ-
status, but a transitional scale).
Aim: This paper describes the process of improving the face validity
and acceptability of the PCOQ-status and PCOQ-change through
cognitive interviews with primary care patients.
Methods: Three rounds of cognitive interviews were held with twenty
patients from four health centres in Bristol. Tourangeau’s model of cog-
nitive processing was adjusted for this research and used to identify
problems. This contained four categories: general comprehension,
temporal comprehension, decision process, and response process. The
resultant pattern of problems was used to assess whether the items
and scales were working as intended, and to make improvements to
the questionnaires.
Results: The problems identified in the PCOQ-status reduced from 41
in round one to seven in round three. The PCOQ-status was both
acceptable to patients and had face valid. As with previous studies,
there were very few decision problems, and most comprehension prob-
lems. The new category of temporal comprehension helped improve
the face validity. The PCOQ-change was less acceptable to patients and
was misunderstood, resulting in it being completed incorrectly by 50%
of patients. It was not taken forward after round one.
Conclusions: Overall the method of cognitive interviewing proved
successful in reducing the number of problems for the PCOQ-status
identified in each round. The PCOQ-change was poorly understood.
Given that this corroborates existing research, this may call into
question the use of transitional questionnaires for measurement of
outcome in primary care, and the highlights need for cognitive test-
ing of such questionnaires prior to quantitative psychometric testing.
A08
Validation and refinement of the HASMID questionnaire:
a measure of health and self-management in diabetes
Jill Carlton, Jackie Elliott & Donna Rowen
University of Sheffield, Sheffield, UK
Correspondence: Jill Carlton
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A08
Aims: Last year we presented the processes undertaken to develop a
new questionnaire to evaluate self-management in diabetes (HASMID
questionnaire). This new study aims to assess the 1) mode of admin-
istration (online and paper-based) and 2) psychometric properties of
HASMID to explore the relationships between some items and fur-
ther refine the instrument.
Methods: Focus groups were held with people living with diabetes to
further reflect on wording of the original 8-item HASMID questionnaire.
Alternative phrasing was suggested for 5 items covering mood, daily
routine, stress and hassle, and all 13 items were put forward for valid-
ation. The validation study consisted of two arms/groups - online or
paper survey. Respondents were asked to complete 13 HASMID ques-
tions, EQ-5D and sociodemographic questions. Potential participants
were recruited via a patient database and social media (email and Twit-
ter), and asked to complete the survey at two time points, so that the
responsiveness of the HASMID instrument could be assessed.
Results: Data collection for time point 1 is ongoing. Recruitment (up
to 1st February 2017) included 1756 and 865 completions to the on-
line and paper versions respectively. Completed responses from
people with diabetes included those with type 1 = 792, type 2 = 1980
and other forms of diabetes = 49. Data collection for time point 2 will
be complete in May 2017. Results will be presented to demonstrate
the reliability (internal consistency) and validity (known-group differ-
ences) of the HASMID instrument. Item correlations, missing data,
floor and ceiling effects, and comparison with EQ-5D scores will be
reported. Reference will be made to the quality of data collected via
paper vs. online completes. The refined HASMID questionnaire will
be presented.
Conclusions: This study will demonstrate the benefits of further val-
idation in the development of instruments. In addition, the consider-
ation of differing modes of administration, and participant
recruitment will be discussed.
Session 2c. Analytic issues
A61
What exactly is a good outcome for total knee replacement (TKR)?
And what proportion of patients experience one?
Anqi Gao, Andrew Price & David Beard
University of Oxford, Oxford, UK
Correspondence: Anqi Gao
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A61
Background: Patient reported outcome measures (PROMS) are used
to assess total knee replacement (TKR). Variation exists in reported
values for the proportion of patients achieving a “good outcome”,
ranging from 53%-79%. The variation could reflect how a “good out-
come” is calculated rather than true differences in study populations.
Aim: Using a large data set, the aim of this study is to determine the
proportion of THR and TKR patients experiencing a “good outcome”
using different criteria, and compare the results obtained via each
method.
Methods: The TKR-PROMs dataset (2012–2013, n = 40,622), including
6-month Oxford Knee Scores (OKS) was investigated. Four common
criteria (shown below) were used to calculate the proportion of pa-
tients achieving a good outcome:
1. ½ standard deviation (SD): For good outcome, the change
pre- to post-operative OKS (ΔOKS) must reach ½ SD of the
average baseline OKS for the population
2. Minimally Important Change (MIC): For good outcome, ΔOKS
must reach the MIC.
3. Satisfaction Criteria: Good outcome defined by ΔOKS or
6-month post-op OKS must reach the patient acceptable
symptom state (PASS) score, which separates the satisfied
from the unsatisfied.
4. Response: Good outcome defined by modified OMERACT-OARSI
criteria, which categorizes patients as “responders” and
“non-responders” based on change in pain and function.
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Results: Good outcome was achieved in 88% (½ SD), 74% (MIC), 71%
(Satisfaction/PASS) and 83% (Response/OARSI) respectively.
Conclusions: In the same population, the proportion of patients
achieving a good outcome can appear different depending on the
metric used. Caution should be applied when viewing the outcome
of data sets using different methods, particularly when using binary
thresholding methods. A universal method of calculating and describing
good outcome should be developed.
A04
Symptom clusters for revising scale membership in the analysis of
Patient Reported Outcome Measures
Agnieszka Lemanska1, Tao Chen1, David P Dearnaley2, Rajesh Jena3,
Matthew Sydes 4 & Sara Faithfull1
1Univerity of Surrey, Guildford, UK; 2Institute of Cancer Research and
Royal Marsden NHS Trust, London, UK; 3Cambridge University Hospitals,
Addenbrookes Hospital, Cambridge, UK; 4MRC Clinical Trials Unit at UCL,
Institute of Clinical Trials and Methodology, London, UK
Correspondence: Agnieszka Lemanska
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A04
Background: Summative scores (individual items pooled together usu-
ally using average) are used to extract and interpret information con-
tained within PROMs. Tools such as University of California, Los Angeles
Prostate-Cancer-Index (UCLA-PCI) arrange items in scales according to
the underlying health concern. Those scales are used to create agglomer-
ate scores. However, this generic approach may be less sensitive e.g. for
varying side-effect profiles due to different treatments. An alternative
method that offers a flexible and adaptive approach of grouping symp-
toms and summarising PROMs is to use symptom clusters (SC).
Aims: To compare SC with scales. To explore the value of SC in the analysis
and interpretation of PROMs and in symptom management for patients.
Methods: A dataset of 843 prostate cancer patients from a randomised
control trial called RT01 was used. PROMs were reported with the UCLA-
PCI. SC were explored with hierarchical cluster analysis (HCA)
(correlation > 0.6). Spearman’s correlation was used to investigate the
strength of the relationship between the items in the UCLA-PCI and
Cronbach’s Alpha to evaluate the reliability of the Urinary Function Scale.
Results: Two SC were identified (Urinary Cluster and Sexual Cluster).
The grouping with SC was different than scales. Two items of the
Urinary Function Scales (“Number of pads” and “Urinary leak interfer-
ing with sexual activity”) were not included in the Urinary Cluster
due to the low correlation which ranged from 0.20-0.21 and 0.31-
0.39 respectively. Cronbach’s Alpha also showed low correlation of
those items with the scale (0.14-0.36 and 0.33-0.44 respectively). All
Urinary Function Scale items were subject to a ceiling effect.
Conclusion: SC provide a study specific approach for adaptive
modelling and interpretation of PROMs. Multiple-item scales should
be evaluated with SC.
A22
Mapping between PROMS, and the Relative Responsiveness
of PROMS : a meta-analytic approach
AE Ades, Daphne Kounali & Guobing Lu
University of Bristol, Avon, UK
Correspondence: AE Ades
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A22
Background:
There is often a need to synthesise treatment effects across trials which
have reported similar but different outcomes. Standardised Mean Differ-
ences are used for this, but this introduces random error. There is also
interest in the relative responsiveness of test instruments, and in the re-
lationships between treatment effects on different - but similar - scales,
sometimes for the purpose of health economic evaluation. The purpose
of this research was to develop methods that achieve all these aims.
Methods:
Statistical methods were developed to synthesise information on
different measurement scales both within and between trials, from
connected networks of trials. (“Connected” here means that each
trial includes at least one test instrument that was used in at
least one other trial). A key assumption was that the larger the
treatment effect on one scale, the larger on the other scales. The
models estimated coherent “mappings” between test instruments.
If applied to standardised effects, the mappings reflect relative
responsiveness. These models were applied to 3 datasets: first to
6 outcomes from 8 trials on biologic therapies in Ankylosing
Spondylitis; second to 9 outcomes from 22 trials on treatments
for Social Anxiety; and third to 6 outcomes on 19 trials of treat-
ments of depression.
Results:
The models fitted the data well, although the mappings varied
slightly from trial to trial with a coefficient of variation approxi-
mately 13%. This may reflect non-linearity in the relationships be-
tween scales. Models based on standardised mean differences
fitted less well, and estimated effects with less precision. It was pos-
sible to rank scales in responsiveness, and identify some scales as
clearly more responsive than others.
Conclusions:
Simultaneous synthesis and estimation of mappings is superior to
standardisation while making fewer assumptions. It provides insights
into the relative responsiveness of test instruments, and can
efficiently estimate “mappings” between outcome scales.
A09
To impute or not to impute? A comparison of statistical
approaches for analysing missing longitudinal patient reported
outcome data in randomised controlled trials
Ines Rombach, Alastair Gray, Crispin Jenkinson & Oliver Rivero-Arias
Nuffield Department of Population Health, University of Oxford, Oxford,
UK
Correspondence: Ines Rombach
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A09
Background: Missing data are a potential source of bias in the results
of randomised controlled trials (RCTs), but are generally unavoidable
in clinical research, particularly in patient reported outcome mea-
sures (PROMs). For longitudinally collected outcomes, often only a
small subset of participants will have complete data for all relevant
time points. Approaches to handling missing longitudinal data in-
clude maximum likelihood (ML), multiple imputation (MI) and inverse
probability weighting (IPW).
Aims: To compare ML, MI and IPW approaches for handling missing
longitudinal PROMs data in RCTs.
Methods: Realistic missing at random data were simulated using
follow-up results from an RCT using the Oxford Knee Score. Simu-
lation scenarios covered sample sizes ranging from 100 to 1,000
with missing PROMs outcome data in 10% to 60% of participants.
Different monotone and non-monotone missing data patterns
were considered. Missing data were addressed using ML, MI and
IPW; data were analysed via multilevel mixed-effects linear regres-
sion models. Root mean square errors in the treatment effects
were used as performance parameters for 1000 simulations.
Results: Non-convergence issues were observed for the IPW ap-
proach for small sample sizes. Bias in the treatment effects in-
creased both with decreasing sample size and increasing
proportions of missing data. MI and ML performed similarly when
the imputation model was restricted to baseline variables. How-
ever, MI was less biased when post-randomisation data were
used in the imputation model. Both approaches were less biased
for non-monotone vs. monotone missing data patterns. IPW intro-
duced more bias than ML and MI across all sample sizes and
missing data scenarios.
Conclusions: MI can offer benefits over ML for handling missing longi-
tudinal PROMs data when additional post-randomisation information is
available. IPW is not recommended to handle missing PROMs data in
RCTs with sample sizes of 1000 participants or less. Minimising missing
data remains important in reducing bias.
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Session 3a. Electronic delivery and CAT
A38
Patients, staff and relatives agree: electronic PROM reporting of
adverse events is a feasible and acceptable adjunct to standard
care in pelvic radiotherapy for cancer: eRAPID (Electronic patient
self-Reporting of Adverse-events: Patient Information and aDvice)
Patricia Holch1,2, Marie Holmes2, Zoe Rodgers2, Sarah Dickinson2, Beverly
Clayton2, Susan Davidson3, Jacqui Routledge3, Julia Glennon3, Ann M
Henry4,2, Kevin Franks4 & Galina Velikova2,4
1Leeds Beckett Universty, Psychology Group, Leeds, West Yorkshire, UK;
2Univeristy of Leeds, Patient reported Outcomes Group, Leeds, West
Yorkshire, UK; 3The Christie NHS Foundation Trust, Manchester, Lancashire,
UK; 4Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, UK
Correspondence: Patricia Holch
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Background: PROMs are routinely used to report late effects of pelvic
radiotherapy however recent reviews (Holch 2016 & Gilbert 2015) have
shown they are under-utilised in the acute phase. We aimed to explore the
acceptability and feasibility of an innovative online self-report and symp-
tom management system (eRAPID) incorporating PROMs into the elec-
tronic patient records in routine cancer care. Currently eRAPID is proving
acceptable and useful to patients undergoing systemic cancer treatment.
Aims: To explore whether radiotherapy patients and their relatives
could see the benefits of online PROM reporting despite daily hos-
pital attendance and if staff would find the electronically accessible
PROM data a useful adjunct to clinical assessments.
Methods: N= 73 participants took part in audio-recorded semi-
structured interviews at St James’s Institute of Oncology, Leeds and The
Christie Hospital, Manchester. Patients (n= 37) undergoing radiotherapy/
concurrent chemotherapy for prostate, colorectal and gynaecological
cancer were interviewed during, on completion and 6 weeks post-
treatment (age range 42–81 mean 62).
Additionally we interviewed key staff (nurses, oncologists and
radiographers) (n = 26) and patient relatives (n = 9). Interviews were
transcribed, coded thematically and managed in NVivo.
Results: Emergent themes revealed patients were positive about the
online PROM system. They thought eRAPID could ‘enable the reporting
of difficult or challenging symptoms’ and be a ‘source of out-of-hours
information’. Staff felt the system would ‘enable support during follow
up’ and ‘fill gaps in toxicity reporting’. Relatives highlighted that eRAPID
would ‘forewarn of potential side effects’ and has the potential to
‘maintain patient’s independence’.
Conclusions: Findings suggest that despite daily hospital attendance
both patients and their relatives stated an online PROM management
system would be beneficial in the acute and late phases of treatment.
Staff agree that eRAPID would be a valuable enhancement to current
service provision. A feasibility study is currently underway at Leeds and
The Christie NHS Trusts.
A24
The eSMART RCT: Comparing electronic Symtpom Management
using the Advanced Symptom Management System (ASyMS) with
standard care for patients during adjuvant chemotherapy
Roma Maguire1, Lisa McCann1, Teresa Young2, Jo Armes3, Jenny Harris3,
Christine Miaskowski4, Grigorios Kotronoulas1, Morven Miller1,
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Patricia Fox11, Eileen Furlong11 & Nora Kearney11
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Dundee, Dundee, UK; 10European Cancer Patient Coalition (ECPC), Brussels,
Belgium; 11University College Dublin School of Nursing, Dublin, Ireland
Correspondence: Teresa Young
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Backgound: ASyMS is a mobile-phone based remote-monitoring and
alert system enabling real-time monitoring of patients’ chemotherapy-
related symptoms. The eSMART RCT compares patient reported out-
comes (PROs) and delivery of care for patients using ASyMS with those
accessing the same Acute Oncology Service through the standard care
pathway at each participating site.
Methods: Patients newly diagnosed with breast, haematological or
colorectal cancer and scheduled to receive at least three cycles of
chemotherapy are recruited into this multinational repeated mea-
sures, parallel-group stratified RCT. 1108 patients will be rando-
mised to either ASyMS or standard care. Patient demographic and
clinical data is collected at baseline and standardised PRO measures
are completed at baseline, during each cycle of chemotherapy and
every 3 months up to 12 months after chemotherapy. The primary
outcome measure is the Memorial Symptom Assessment Scale.
Secondary measures include: Functional Assessment of Cancer
Therapy-General, Supportive Care Needs Survey-Short Form 34,
State-Trait Anxiety Inventory, Communication and Attitudinal Self-
Efficacy scale for cancer, Work limitations Questionnaire, EuroQol
and Client Services-Receipt Inventory.
Results: RCT data collection started in May 2016, and to date 432 pa-
tients have been recruited from 11 centres in 5 countries including
participants from the UK.
Conclusion: Patients are willing to accept randomisation into the
study and recruitment is ongoing. An overview of the trial aims and
design and a reflection on the challenges faced in setting up the
study and the solutions implemented to overcome them will be
provided.
Acknowledgement
The study is funded by a grant from the EC: FP7-HEALTH-2013-INNOVATION-
1 Grant Agreement Number 602289.
A27
Quality of life assessment is more efficient precise when
conducted using a computer adaptive testing protocol : an
international study
Chris Gibbons
University of Cambridge, Cambridge, UK
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A27
Background: We calibrated four item banks using the WHOLQOL-100
quality of life assessment and deployed them online as computer
adaptive tests using the Concerto assessment platform.
Methods: The WHOQOL-CAT was developed using Concerto hosted
online. Item selection and scoring was conducted using the partial
credit ‘Rasch’ model with maximum likelihood estimation. The
WHOQOL-CAT provides four separate unidimensional assessments of
quality of life in physical, psychological, social and environmental
domains.
Results: 4886 patients from 115 countries, including 578 from the
UK, completed the WHOQOL-CAT. 1745 participants reported a long-
term condition and 586 participants reported multiple long-term
conditions (multimorbidity). Average age was 35 years (range 18 to
92) and 47% of the sample were female. Assessments were con-
ducted with a mean reliability (Alpha Cronbach’s equivalent) of .83
(range .82-.88) using, on average, 4.8 items per domain. Average as-
sessment time was 95 seconds (4.8 seconds per item). Participants
who self reported long-term conditions reported significantly lower
scores on the physical quality of life domain (t = −3.06, P < 0.01) but
not on any of the other four domains.
Conclusions: When administered to a diverse international sample of
participants, the WHOQOL-CAT compares favourably to the WHOQOL-
BREF and WHOQOL-100. The WHOQOL-CAT is between 80% and 25%
shorter than the paper-based measures and is slightly more reliable.
Accurate QoL assessment across four domains can be made in under
two minutes. Advantages of CAT which are typically demonstrated
using simulated CAT administration ‘in the lab’ appear to be evident in
studies using data collected ‘in the real world’ from a diverse inter-
national sample.
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The PROMIS Profile 29 allows valid comparisons of patient-
reported health over France, Germany and the UK
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Background: Patient-Reported outcome measures are increasingly
utilized. Comparability of such measures over different languages
needs to be established to allow cross-national research. We investi-
gate the comparability of the PROMIS Profile 29, a generic health-
related quality of life measure, in general population samples in the
UK, France and Germany.
Methods: A web based survey was simultaneously conducted in the
UK (n = 1,509), France (1,501) and Germany (1,502). Along with the
PROMIS profile 29, the participants answered sociodemographic
questions as well as the EQ-5D. We tested measurement invariance
by means of multi-group confirmatory factor analysis. Differences in
the health-related quality of life between countries were modeled by
linear regression. We present general population reference data for
the included PROMIS domains utilizing plausible value imputation
and quantile regression.
Results: Multi-group confirmatory factor analysis of the PROMIS
Profile 29 revealed strong measurement invariance between different
languages (CFI = 0.952, TLI = 0.950, RMSEA = 0.049, SRMR = 0.041) .
We observed significant differences in patient-reported health
between countries, which could be partially explained by differences
in overall ratings of health. The physical function and pain interfer-
ence scales showed considerable floor effects in the normal popula-
tion in all countries.
Conclusion: Scores derived from the PROMIS Profile 29 can be read-
ily compared across the UK, France and Germany. Due to the use of
plausible value imputation, the presented general population refer-
ence values can be compared to data collected with other PROMIS
short forms or computer-adaptive tests.
Session 3b. Concepts and models
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The Development and Use of Conceptual Models
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Background: Conceptual models (CMs) provide visual representation
of disease related concepts and their causal linkages. CMs can aid
the development and/or revision of patient reported outcome (PRO)
instruments; guiding decisions around what and how to measure
(e.g. identification of clinical trial endpoints and suitable PROs).
Aims: To undertake a targeted review of the use and development
of CMs in published PRO research, using examples to make sugges-
tions for best practice for developing and using effective CMs.
Methods: A targeted literature search was undertaken in Pubmed
(2007–2017) for publications associated with CM development asso-
ciated with PROs. A separate hand search was conducted in relevant
conference websites, such as ISPOR to identify CM guidelines and/or
publications. Data was reviewed for CM development methods to
guide best practice suggestions.
Results: Of 47 abstracts identified and reviewed, 12 were found to
be potentially relevant for full text review; one didn’t include a CM
and was therefore excluded. Five of the included publications in-
cluded patient research (qualitative interviews/focus groups) in their
CM development; another five only included information extracted
from a literature review (qualitative patient data), and one lacked
development details. The majority of CMs included domains and
sub-domains associated with symptoms, impact on health related
quality of life, and associated treatment impacts. Only three studies
reported including data from/review by clinical experts. No best
practice guidelines for CM development were identified; although
publications specific to PRO content validity were. These state that
qualitative data should be included in research to confirm the
conceptual framework of PROs used in trials.
Conclusions: CMs are important for identifying disease concepts
from the patient perspective which is essential for identifying trial
endpoints and confirming PRO content validity; a necessity for regu-
lators. For a CM to fully explore patient perspective, the inclusion of
patient data during the development appears to be essential.
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Chronobiology and PROMs: a systematic scoping review for
patients with chronic health conditions
Antoinette Davey, Ian Porter, Colin Green & Jose M Valderas
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Background: Aggregate estimates of Patient Reported Outcome
Measures (PROMs) are being increasingly used for measuring health care
providers’ performance. There is also growing recognition of the potential
of the individual use in enhancing patient centredness in the provision of
clinical care. The impact of biological, environmental and social cyclical
phenomena on intra-individual PROMs estimates has previously received
little attention because of the implicit assumption that it may be negligible
for group-level estimates. It may be however significant for individual use.
Aims: To map the key concepts that underpin research in the
chronobiology of PROMs as well to identify and summarize available
evidence for patients with chronic conditions.
Methods: We conducted a systematic search and review of the litera-
ture, following the PRISMA statement and a protocol in the PROS-
PERO database. Electronic databases (MEDLINE, Embase, PsychInfo,
and CINHL) were searched using MeSH terms, free text and previ-
ously developed search strategies. All documents literature for
chronobiology and PROMs focusing on chronic conditions were in-
cluded, without any restriction. Two reviewers independently applied
the criteria in the consecutive stages of title, abstract and full-text
screening. A narrative synthesis of the data will be conducted.
Results: 2098 unique titles were identified, the majority of them
(1460, 69.6%) were published in the last 10 years. The review is
currently in progress and full results will be ready to report at the
conference. Literature consists of quantitative analyses of observational
data, and reports from experimental studies. Evidence have been iden-
tified for daily variations of patient reported outcomes as a result of
biological rhythms for a range of chronic conditions, such as arthritis,
asthma, migraines, depressive symptoms and cognitive status.
Conclusions: If chronobiology and its effects can be identified and
therefore considered in a policy setting this will facilitate further use
of PROMs in an individualised patient setting.
A76
Diversity in values across the life-course
Joanna Coast1,2
1University of Bristol, Bristol, UK; 2NIHR CLAHRC West, Bristol, UK
Health and Quality of Life Outcomes 2017, 15(Suppl 1):A76
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Background: This paper considers the possibilities for the application
of capability measures within a life course framework. Life course
concepts focus on interlinking between generation and age. This
may be a particularly useful way to think about values within a
capability framework, given the importance of context within the
approach and the potential for diversity in considering capability to
different groups.
Aims: To explore the extent to which ‘what people have reason to
value’ differs at different points in the life course.
Methods: (i) Examination of existing capability measures for adults,
older people and end of life, generated using similar methods (in-
depth interviews with the populations of interest and valuation using
best-worst scaling/discrete choice techniques) to determine similar-
ities and differences in values at different points of the life-course; (ii)
Examination of issues that would arise in fully exploiting a life-course
approach to capability measurement.
Results: Measures for adults and older people are broadly similar but
there are important differences that may reflect life course issues,
particularly in relation to differences between Achievement (adults)
and Role (older people), and between Stability (adults) and Security
(older people). The end of life measure has much greater variation
within its attributes, appearing to reflect concerns with anticipated
lack of capacity at end of life. Important issues in generating a com-
prehensive life-course approach include delineating points on the life
course at which values changes, integrating measures across differ-
ent stages of life, and generating appropriate measures for children
that capture both well-being and well-becoming, and rapid changes
in development and capacity.
Conclusions: Despite many challenges, a life-course approach to
capability measurement may well offer an approach that accounts for
much of the diversity in values without requiring new capability indices
for every situation; pursuing this approach would be a worthwhile
endeavour.
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Understanding DEMQOL scores: Minimal Important Differences
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Correspondence: Sarah Smith
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Background & Aims: DEMQOL (a measure of HRQL in dementia) has
undergone extensive psychometric evaluation but no minimal import-
ant difference (MID) has been reported. MID statistics are enhanced by
qualitative, descriptive statements about what it means to change from
one score to another over time.
Methods: In a sample of 875 patients attending a first Memory
Assessment Clinic appointment and 6 month follow up, we used
anchor-based (mean score difference between those reporting “no
difference” and those reporting “a little” difference in HRQL) and
distribution-based (effect sizes of 0.5) to quantify MID. We developed
three example scenarios of MID change and identified the item
descriptions related to this change.
Results: Anchor-based and distribution-based methods produced
different estimates of MID (1.92 v 6.15 respectively). Given the known
difficulties in interpreting the former we used the distribution-based
statistic to develop descriptive item scenarios.
People with dementia at the high end of the HRQL scale (score >66)
are most likely to report low negative emotion (‘a little’ worried, frus-
trated, and fed up). In the middle of the scale (56) participants also
report worry about cognitive function (‘a little’ worried about forget-
ting who people are and having difficulty making decisions; ‘quite a
bit’ worried about forgetting things that happened recently). At the
low end of the scale (38) participants additionally report greater
worry about social situations (‘a lot’ worried about how they get on
with others and making themselves understood). In general, a 6
point (MID) change for each of these scenarios resulted in descriptive
changes equivalent to one response category.
Conclusions: Using Rasch analyses to develop the scores for DEM-
QOL has given us important information about the location of each
item on the continuum. We have linked this information to MID
statistics to begin to develop a meaningful understanding of change.
This research was commissioned and funded by the Department of
Health Policy Research Programme (Using Patient Reported Outcome
Measures to Assess Quality of Life in Dementia, 0700071). The views
expressed in this publication are those of the authors and not
necessarily those of the Department of Health.
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Background: There are challenges in measuring self-reported health
in children, and in valuing the resulting health states. For example,
whose preferences should be used to value the health states defined
by a preference-based measure designed to measure children’s
health and to provide utilities for economic evaluation? The EuroQol
Group has developed a child-friendly version of the EQ-5D - the EQ-
5D-Y - but to date there have been no value sets available to support
its use in decision-making.
Aims: (i) To provide an overview of the challenges in defining and
valuing children’s health states; (ii) to report a discrete choice experi-
ment (DCE) study undertaken to obtain latent scale values for the
EQ-5D-Y; and (iii) to report a methodological study, undertaken in
parallel, to explore and compare a range of stated preference
methods for valuing EQ-5D-Y health states. The ultimate aim is to
provide an EQ-5D-Y value set for the UK, and a set of methods that
can be recommended for use in other countries requiring an EQ-5D-
Y value set.
Method: The DCE was administered via an internet survey. 1,000
adult general public respondents were asked to consider EQ-5D-Y
health states from the perspective of a 10-year-old child. The meth-
odological study was administered via computer-assisted personal
interviews, and tested four techniques: visual analogue scale, DCE,
time trade-off and an innovative ‘location-of-dead’ approach. 300
adult general public respondents were asked to value both EQ-5D
health states considering their own health AND EQ-5D-Y health
states for a 10-year-old child.
Results: This presentation explored the normative and practical
challenges involved in valuing child health states and reported the
preliminary findings of the empirical research (full results of the DCE
study and findings from a pilot of the methodological study).
Conclusions: This research has advanced the understanding of the
valuation of children’s health outcomes and represents the first stage
in the development of EQ-5D-Y value sets.
A17
Selection of bolt-ons after factor analysis: are linear regression
models a useful technique?
Aureliano Paolo Finch, John E Brazier, Clara Mukuria
University of Sheffield, Sheffield, UK
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Background: It is recognized that the EQ-5D may miss dimensions
important for the HRQoL of patients. When this happens, a possible
solution is adding bolt-ons. Finch et al., (2017) have recently shown
that bolt-on can be systematically idenfied using factor analysis. This
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technique pinpoints to a list of factors and items. However, factors
and items cannot be added to the EQ-5D simultanously, as this
would affect the measure’s feasibility. Hence, it remains unclear how
to select bolt-ons from the identified list. This study investigates the
possibility of using linear regression models for the selection of bolt-
ons after factor analytic identification. It tests six factors, energy/vital-
ity, satisfaction, relationships, hearing, vision and speech, and 37
items loading on them.
Methods: Two tests were performed. In the first test, linear regres-
sions were fitted to determine whether different factors and items
helped explain variations of self reported health as measured by the
VAS health scale. Bolt-on relevance was judged comparing the
strength, direction and statistical significance of unadjusted b coeffi-
cient. In the second test, linear regressions were fitted to further in-
vestigate whether different factors and items helped explain the
negative effect of six chronic conditions on self reported health. A re-
duction in the coefficients for the chronic conditions dummies meant
that the factor or item detected the effect.
Results: Energy/vitality, relationships and satisfaction reported sub-
stantially larger unadjusted b coefficients than speech, vision and
hearing. Also items loading on energy/vitality, relationships and satis-
faction generally presented larger coefficient than those of items
loading on speaking, vision and hearing. The second test did not
detect b coefficient decrements for the chronic conditions dummies
when testing factors, but consistent b coefficient decrements when
testing items.
Conclusions: The first test appears a useful technique for bolt-on
selection after factor analytic identification. Further research is
needed for the second test.
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New methods for analysing the distribution of EQ-5D observations
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Background: This paper proposes and tests new methods (Health
State Density Index, Health State Density Curve and estimated Power
Law functions) we have developed to characterise and summarise
the distribution of health states in Patient Reported Outcome (PRO)
data within a sample or population of patients. The purpose of these
methods is to measure how diverse any given patient group is. These
results are relevant to clinicians responsible for service delivery - for
example, a homogenous population of patients can be managed by
protocol based interventions whilst heterogeneity requires more
complex service delivery. The methods also have applications in
comparing the descriptive performance of alternative instruments
(e.g. EQ-5D-5 L vs EQ-5D-3 L); and in understanding the underlying
nature of changes in health states resulting from treatment in clinical
settings or trials.
Methods: Using both the new methods and existing methods from in-
formation theory (e.g. Shannon’s Index), we compare the distribution of
EQ-5D health profiles across three groups of patients in two data sets:
Cambridgeshire Community Services NHS’s electronic patient records
for the EQ-5D-5 L; and the Health Survey for England 2014 for the EQ-
5D-3 L. To explore the link between changes in the distribution of self-
reported health and health changes, we use data from the NHS PROMs
programme which reports EQ-5D-3 L before and after four surgical pro-
cedures. The properties of the various methods are further examined
using simulated data sets.
Conclusions: Our results show that each method has different
properties and will give different insights into patients’ data. For
example, the Shannon index (absolute and relative) is not sensitive
to random variations but decreases slowly with “rare health states”.
The HSDI decreases slowly with random variations and is strongly
affected by “rare” health states with large decreases towards zero (total
inequality). We discuss the implications for the interpretation and ana-
lysis of PRO data.
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Putting the P back into PROMs - using patient valuations of EQ-5D
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Background: The English NHS has been collecting EQ-5D data for all
publicly-funded patients undergoing four types of elective surgery
since April 2009. One of the intended aims of these data is to inform
patients’ choice of hospital. To this end NHS Digital publishes per-
formance indicators reflecting the change in EQ-5D utility scores.
These are calculated using the UK TTO general population value set.
While the approach of using general population value sets is justified
in many applications, for example when evaluating new technologies
for adoption into collectively funded healthcare systems, it appears
indefensible when HRQoL data are used to inform individual pa-
tients’ decisions about where to receive care.
Aims: This study explores whether using patient weights instead of
general population weights leads to a) different rankings of hospital
providers and b) changes in providers deemed performance outliers.
Methods: We use data EQ-5D health state data and EQ-VAS data
from over 300,000 patients who underwent hip and knee replace-
ment surgery in England between April 2009 and March 2015 to de-
rive procedure-specific patient population tariffs. We apply these
tariffs to the EQ-5D health state data before and after surgery to cal-
culate case-mix adjusted hospital performance estimates. Changes in
ranking are calculated for each patient for their 10 closest hospitals.
Changes in outlier status are calculated for all providers in England.
Results: Patient population tariffs assign lower weight to pain & dis-
comfort and higher weights to anxiety & depression than the UK
general population TTO tariff. Hospital rankings vary depending on
the weights used. There is little impact on outlier identification.
Conclusion: Patients may be better served with hospital performance
estimates that reflect their own values and are therefore more rele-
vant to their decisions. This finding has important implications for
the national PROM programme in England.
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